QYResearch: The Baby Diaper Rash Cream revenue is expected to reach 72.4 M USD in 2021 www.qyresearch.com
Contact
Beijing Hengzhou Bozhi International Information Consulting Web: qyresearchglobal.com | qyresearcheurope.com | qyresearch.com | qyresearch.com/english | qyresearchjapan.com TEL:+86-13660489419, Office:+86-2086655165 Media: press@qyresearch.com Marketing: sales@qyresearch.com
www.qyresearch.com
Facebook: @QYResearchOfficial ,Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智
QYResearch • Diaper rash is often related to wet or infrequently changed diapers, skin sensitivity, and chafing. It usually affects babies, though anyone who wears a diaper regularly can develop the condition. • Baby Diaper Rash Cream is a type of non-prescription drug for baby to treat diaper rash.
www.qyresearch.com
QYResearch • According to QYResearch, The Baby Diaper Rash Cream revenue was 56.4 M USD in 2015 and is expected to reach 72.4 M USD in 2021, growing at a CAGR of 4.25% from 2015 to 2021. The global leading players in this market are Yumeijing, Fiverams, Himalaya Wellness, YingZifang, Sudocrem, Johnson & Johnson, Bayer, Pigeon, NUK, AVENT, HITO, Burt’s Bees, Earth Mama Angel Baby, Eucerin and etc. • Currently, a major challenge affecting the market growth is the limitation of downstream market. As large demand of healthy products at home and abroad, many companies began to enter the field. www.qyresearch.com
QYResearch Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this area, the future will still have more new investment enter the field. In the next five years, the consumption volume will keep slow increasing, as well as the consumption value.
www.qyresearch.com